Clopidogrel Impurity 31 CAS 19995-38-1

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.19995-38-1
Molecular FormulaC6H7ClS
Molecular Weight146.64 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Clopidogrel Impurity 31 CAS 19995-38-1 chemical structure

Description

CATO supplies Clopidogrel Impurity 31 (CAS 19995-38-1), a pharmacopoeial impurity reference standard (molecular formula C6H7ClS, MW 146.64 g/mol) used for the identification and quantification of trace impurities in APIs.

Clopidogrel Impurity 31 (C6H7ClS) contains sulfur-containing functionality, chlorine substitution. Halogen substitution raises its density and boiling point; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

CATO manufactures Clopidogrel Impurity 31 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC6H7ClS
Molecular Weight146.64 g/mol
Purity97%+
StorageStore at 2-8°C, keep tightly closed to prevent evaporation
Solubility (reference)Soluble in methanol, acetonitrile, DMSO
StabilityMay oxidize slowly on prolonged air exposure
Degree of Unsaturation (DBE)3.0
UV AbsorptionUV-absorbing
CAS Registry Year (est.)1962
Halogen ContentCl-containing
Sulfur Atoms1

Related Clopidogrel Standards

Recommended Standards

Why CATO?